-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Poster Walk on Current Challenges in Treating Hematologic Malignancies: Live Q&A

PhD Trainee
Program: ASH Poster Walks
Wednesday, December 9, 2020: 7:00 AM-8:00 AM
Moderator:
Disclosures:
No relevant conflicts of interest to declare.
Panelists:
Peter JM Valk, PhD, Erasmus University Medical Center , Arnold Ganser, Hannover Medical School , Phoebe Joy Ho, MBBS, DPhil, FRACP, FRCPA, Royal Prince Alfred Hospital , Mariana Nassif Kerbauy, MD, Hospital Israelita Albert Einstein , Perla R. Colunga Pedraza, MD, Servicio De Hematología, Hospital Universitario , Simone Claudiani, Imperial College London , Per Ljungman, MD, PhD, Karolinska University Hospital and Louise Pettersson, Hallands sjukhus Halmstad
Disclosures:
No relevant conflicts of interest to declare.
The following abstracts will be featured in this session:

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients, Mariana Kerbauy

Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia,  Simone Claudiani

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care, Perla Colunga Pedraza

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH), Per Ljungman

DNA-Based Methods for Measurable Residual Disease Detection in NPM1-Mutated Acute Myeloid Leukemia; Establishment of Cut-Offs for qPCR, Digital Droplet PCR and Targeted Deep Sequencing, Pettersson

See more of: ASH Poster Walks
<< Previous Session | Next Session >>